scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH)
CUSIP: 810648105
Q3 2019 13F Holders as of 30 Sep 2019
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 53,364,241
- Total 13F shares
- 7,577,638
- Share change
- +207,104
- Total reported value
- $44,502,550
- Price per share
- $5.89
- Number of holders
- 24
- Value change
- +$1,469,868
- Number of buys
- 11
- Number of sells
- 16
Quarterly Holders Quick Answers
What is CUSIP 810648105?
CUSIP 810648105 identifies SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 810648105:
Top shareholders of SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
6.4%
|
3,409,865
|
$10,877,000 | — | 30 Jun 2019 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
6.1%
|
3,247,005
|
$10,358,000 | — | 30 Jun 2019 | |
| Eversept Partners, LP |
13F
|
Company |
0.33%
|
174,297
|
$556,007 | — | 30 Jun 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.17%
|
88,961
|
$284,000 | — | 30 Jun 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.12%
|
66,570
|
$213,000 | — | 30 Jun 2019 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
61,500
|
$196,000 | — | 30 Jun 2019 | |
| Alambic Investment Management, L.P. |
13F
|
Company |
0.11%
|
59,847
|
$191,000 | — | 30 Jun 2019 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.09%
|
45,500
|
$145,000 | — | 30 Jun 2019 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.07%
|
36,921
|
$118,000 | — | 30 Jun 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.06%
|
33,780
|
$108,000 | — | 30 Jun 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
32,683
|
$104,000 | — | 30 Jun 2019 | |
| Paloma Partners Management Co |
13F
|
Company |
0.06%
|
30,000
|
$96,000 | — | 30 Jun 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.03%
|
18,580
|
$60,000 | — | 30 Jun 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
13,611
|
$43,000 | — | 30 Jun 2019 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.02%
|
12,877
|
$41,000 | — | 30 Jun 2019 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.02%
|
11,544
|
$37,000 | — | 30 Jun 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
4,961
|
$16,000 | — | 30 Jun 2019 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.01%
|
4,523
|
$14,000 | — | 30 Jun 2019 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
4,211
|
$13,000 | — | 30 Jun 2019 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.01%
|
3,486
|
$11,000 | — | 30 Jun 2019 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
3,211
|
$10,000 | — | 30 Jun 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
1,808
|
$5,000 | — | 30 Jun 2019 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,265
|
$4,000 | — | 30 Jun 2019 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
1,025
|
$3,000 | — | 30 Jun 2019 | |
| MEEDER ASSET MANAGEMENT INC |
13F
|
Company |
0%
|
967
|
$3,000 | — | 30 Jun 2019 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
768
|
$2,450 | — | 30 Jun 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
411
|
$1,000 | — | 30 Jun 2019 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0%
|
357
|
$1,000 | — | 30 Jun 2019 |
Institutional Holders of scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) as of Q3 2019
As of 30 Sep 2019,
scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,577,638 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, Eversept Partners, LP, RENAISSANCE TECHNOLOGIES LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, Alambic Investment Management, L.P., MORGAN STANLEY, JPMORGAN CHASE & CO, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
24
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2019 vs Q2 2019 Across Filers
Q2 2019 holders
28
Q3 2019 holders
24
Holder diff
-4
| Investor | Q2 2019 Shares | Q3 2019 Shares | Share Diff | Share Chg % | Q2 2019 Value $ | Q3 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.